IL314241A - Topical compositions and uses therof - Google Patents

Topical compositions and uses therof

Info

Publication number
IL314241A
IL314241A IL314241A IL31424124A IL314241A IL 314241 A IL314241 A IL 314241A IL 314241 A IL314241 A IL 314241A IL 31424124 A IL31424124 A IL 31424124A IL 314241 A IL314241 A IL 314241A
Authority
IL
Israel
Prior art keywords
local preparations
preparations
local
Prior art date
Application number
IL314241A
Other languages
English (en)
Hebrew (he)
Original Assignee
Topadur Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topadur Pharma Ag filed Critical Topadur Pharma Ag
Publication of IL314241A publication Critical patent/IL314241A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL314241A 2022-03-02 2023-03-01 Topical compositions and uses therof IL314241A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22159773 2022-03-02
PCT/EP2023/055085 WO2023166013A1 (en) 2022-03-02 2023-03-01 Topical compositions and uses therof

Publications (1)

Publication Number Publication Date
IL314241A true IL314241A (en) 2024-09-01

Family

ID=80625301

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314241A IL314241A (en) 2022-03-02 2023-03-01 Topical compositions and uses therof

Country Status (10)

Country Link
US (1) US20250161309A1 (https=)
EP (1) EP4486349A1 (https=)
JP (1) JP2025506878A (https=)
KR (1) KR20240154529A (https=)
CN (1) CN118891047A (https=)
AU (1) AU2023227111A1 (https=)
CA (1) CA3248815A1 (https=)
IL (1) IL314241A (https=)
MX (1) MX2024009874A (https=)
WO (1) WO2023166013A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230129639A (ko) * 2022-03-02 2023-09-11 연세대학교 산학협력단 이중작용 pde5 억제제/질산유기에스터의 국소 혈류 증진을 위한 경피 투약 형태

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596812A (en) 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
US4193619A (en) 1978-05-15 1980-03-18 Acme General Corporation Door latch
CA2395558C (en) 1997-11-12 2007-07-17 Bayer Aktiengesellschaft Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
GB9823103D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100358083B1 (ko) 2000-02-17 2002-10-25 에스케이케미칼주식회사 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도
CA2784788A1 (en) 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for treating peripheral vascular disease
MX2019013626A (es) 2017-05-22 2020-01-13 Topadur Pharma Ag Modo de accion dual novedoso de activadores de guanilato ciclasa solubles e inhibidores de fosfodiesterasa y usos de los mismos.

Also Published As

Publication number Publication date
JP2025506878A (ja) 2025-03-13
CN118891047A (zh) 2024-11-01
AU2023227111A1 (en) 2024-07-25
US20250161309A1 (en) 2025-05-22
CA3248815A1 (en) 2023-09-07
WO2023166013A1 (en) 2023-09-07
WO2023166013A9 (en) 2024-05-23
KR20240154529A (ko) 2024-10-25
EP4486349A1 (en) 2025-01-08
MX2024009874A (es) 2024-08-20

Similar Documents

Publication Publication Date Title
IL279897A (en) Fusosome compositions and uses thereof
IL287456A (en) Cannabinoid compositions and methods of using
IL286717A (en) Immunotherapeutic compositions and use thereof
DK3784283T3 (da) Cannabidiopræparater og anvendelser deraf
IL311339A (en) Gelma polymer compositions and uses thereof
IL280317A (en) Anti-avb8 antibodies and compositions and uses thereof
EP4262883C0 (en) PEG LIPIDS AND LIPID NANOPARTICLES
IL284878A (en) Trem compositions and uses thereof
EP4499707A4 (en) CCR8 ANTIBODIES AND THEIR USES
EP4468534A4 (en) CONNECTOR SHEET AND CONNECTOR
EP4204751A4 (en) FREEZE-DRYING SYSTEMS AND PROCESSES
IL311837A (en) Compositions targeting bcma and methods of use thereof
IL289819A (en) Benzenesulfonamide derivatives and uses thereof
IL312541A (en) Compositions and treatments with nirogacestat
IL304607A (en) Compositions comprising pedf-derived short peptides (pdsp) and uses thereof
IL310931A (en) 6-aza-quinoline derivatives and related uses
EP4447738A4 (en) EYELASH EXTENSION SYSTEMS AND METHODS
IL304449A (en) Lipid compounds and lipid nanoparticle compositions
DK4288456T3 (da) Anti-met-antistoffer og anvendelser deraf
KR20240101546A9 (ko) 항-글리코-lamp1 항체 및 그의 용도
IL308375A (en) Anti-tmprss6 antibodies and uses thereof
EP4198040C0 (de) Pt-dpephos-iod-komplex und pt-dpephos-brom-komplex
EP4504190A4 (en) OXADIAZOLE HDAC6 INHIBITORS AND THEIR USES
IL314241A (en) Topical compositions and uses therof
IL279877A (en) Ivosidenib forms and pharmaceutical compositions